Provision of an Auto-Injector Partner

The UK Ministry of Defence (UK MOD) has an identified and likely future requirement for the production of single and triple therapy auto-injector devices for intramuscular administration. The auto-injectors should be capable of storing up to three Active pharmaceuticals ingredients in a single, dual or triple chambered device. Full operating capability will require the final drug product to be submitted to Regulatory Agencies in the EU and the United Kingdom with the intent for full licensure / marketing authorisation (MA). The Chemical Biological Radiological Nuclear Team (CBRN) is therefore seeking to appoint a partner to manufacture current Auto-injector requirements with future options to manufacture other similar devices as they arise throughout the contractual period.